日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics

Blinatumomab 对 KMT2A 重排 ALL 患儿的持续疗效:长期结果、毒性和药代动力学

Vieira Martins, Miguel; de Lorenzo, Paola; Kotecha, Rishi S; Attarbaschi, Andishe; Escherich, Gabriele; Nysom, Karsten; Stary, Jan; Ferster, Alina; Brethon, Benoit; Locatelli, Franco; Schrappe, Martin; Scholte-van Houtem, Peggy E; Valsecchi, Maria G; Huitema, Alwin D R; Pieters, Rob; van der Sluis, Inge M

Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness

更正:基于模型的皮下注射纳武利尤单抗替代给药策略以提高成本效益

Wang, Yan; Bukkems, Laura H; Ter Heine, Rob; van Hasselt, J G C; Koolen, S L W; Hendrikx, J J M A; Van der Hulle, Tom; Kapiteijn, Ellen; Zwaveling, Juliette; Becker, Annemarie; van den Heuvel, Michel M; Theelen, Willemijn S M E; Oude Munnink, Thijs H; Smit, Egbert F; Guchelaar, Henk-Jan; Moes, Dirk Jan A R

Model-Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness

基于模型的皮下注射纳武利尤单抗替代给药策略以提高成本效益

Wang, Yan; Bukkems, Laura H; Ter Heine, Rob; van Hasselt, J G C; Koolen, S L W; Hendrikx, J J M A; Van der Hulle, Tom; Kapiteijn, Ellen; Zwaveling, Juliette; Becker, Annemarie; van den Heuvel, Michel M; Theelen, Willemijn S M E; Oude Munnink, Thijs H; Smit, Egbert F; Guchelaar, Henk-Jan; Moes, Dirk Jan A R

Leveraging fragment-based drug discovery to advance 3D scaffolds into potent ligands: application to the histamine H(1) receptor

利用基于片段的药物发现方法将3D支架转化为高效配体:以组胺H(1)受体为例

Dekker, Tom; van Linden, Oscar P J; Lim, Herman D; Dekker, Mabel E; Vischer, Henry F; Leurs, Rob; van der Meer, Tiffany; Buzink, Maurice C M L; Hamilton, David J; Zarzycka, Barbara; Janssen, Elwin; Wijtmans, Maikel; de Esch, Iwan J P

Hybrid drug-coated balloon strategy for coronary bifurcation lesions: a systematic review and meta-analysis

混合药物涂层球囊治疗冠状动脉分叉病变:系统评价和荟萃分析

Dillen, Daimy M M; van Beek, Konrad A J; Vermeer, Amy J E; Vlaar, Pieter-Jan; El Farissi, Mohamed; Demandt, Jesse P A; Eerdekens, Rob; van Het Veer, Marcel; Tonino, Pim A L; Teeuwen, Koen

Cross-disciplinary methodologies for whole-person research - insights from EMPOWER2024

面向全人研究的跨学科方法论——来自 EMPOWER2024 的启示

Buvat, Irène; Aarntzen, Erik; Badawi, Ramsey D; Ballesta, Annabelle; Bock, Christoph; Chuah, Chen-Nee; Fisher, Jasmin; Graff, John-Paul; Ilan, Yaron; Isambert, Hervé; Ivanov, Plamen Ch; Izu, Leighton T; Koenen, Hans Jpm; Langevin, Helene; Lewis, David Y; Liem, David A; Mackerodt, Jonas; Pires, Manuel; Sundar, Lalith Ks; Tawakol, Ahmed; Ter Horst, Rob; van Cranenbroek, Bram; Weigelin, Bettina; Cherry, Simon R; Beyer, Thomas

Quality Improvement Intervention for Reducing Acute Treatment Times in Ischemic Stroke: A Cluster Randomized Clinical Trial

改善缺血性卒中急性期治疗时间的质量改进干预措施:一项整群随机临床试验

Hansen, Daniël; den Hartog, Sanne J; van Leeuwen, Nikki; Boiten, Jelis; Dinkelaar, Wouter; van Doormaal, Pieter J; Eijkenaar, Frank; Emmer, Bart J; van Es, Adriaan C G M; Flach, H Zwenneke; Gons, Rob; den Hertog, M Heleen; Imani, Farshad; Janssen, Paula M; Kortman, Hans; Kruyt, Nyika D; Kuhrij, Laurien S; van der Leij, Christiaan; Lo, T H Rob; van der Lugt, Aad; Lycklama À Nijeholt, Geert; Martens, Jasper M M; Nederkoorn, Paul J; Piet, Jurgen; Remmers, Michel J M; Roos, Yvo B W E M; Silvis, Suzanne M; Stolze, Lotte J; Stomp, Wouter; van Tuijl, Julia H; Truijman, Martine T B; Vermeer, Sarah E; van Walderveen, Marianne A A; van den Wijngaard, Ido R; Van der Worp, H Bart; Yo, Lonneke; Dippel, Diederik W J; Lingsma, Hester F; Roozenbeek, Bob

Prolonged disease remission of the chronic immunological skin disorder hidradenitis suppurativa with adjunctive bacteriophage therapy

辅助噬菌体疗法可延长慢性免疫性皮肤病化脓性汗腺炎的病情缓解期

Bens, Lene; Vanhoutvin, Tine; Green, Sabrina; Gorivale, Sayali; Almeida, Madalena; Romaniuk, Filip; Hillary, Tom; Jansen, Daan; Matthijnssens, Jelle; Vermeire, Séverine; Sabino, João; Depypere, Melissa; Devolder, David; Spriet, Isabel; Debaveye, Yves; De Munter, Paul; Onsea, Jolien; Metsemakers, Willem-Jan; van Noort, Vera; Pirnay, Jean-Paul; Merabishvili, Maya; Wagemans, Jeroen; Lavigne, Rob; Van Laethem, An

UBE3A promotes foam cell formation and counters remyelination by targeting ABCA1 for proteasomal degradation.

UBE3A 通过靶向 ABCA1 进行蛋白酶体降解,促进泡沫细胞形成并抑制髓鞘再生

Loix Melanie, Vanherle Sam, Bolkaerts Laura, Verberk Sanne G S, Punt Mattijs, Wouters Flore, Moonen Brecht, Verhagen Rob, Van Wouw Suzanne A E, Jongejan Aldo, Distel Ben, Elgersma Ype, Haidar Mansour, Zelcer Noam, Hendriks Jerome J A, Bogie Jeroen F J

Real-world outcomes of the CROSS regimen in patients with resectable esophageal or gastro-esophageal junction adenocarcinoma: a nationwide cohort study in the Netherlands

CROSS方案治疗可切除食管或胃食管交界处腺癌患者的真实世界疗效:一项荷兰全国性队列研究

van Laarhoven, Hanneke; Verhoeven, Rob; van Berge Henegouwen, Mark; Mohammad, Nadia Haj; van Hillegersberg, Richard; Slingerland, Marije; Muijs, Christina T; Wijnhoven, Bas; Mostert, Bianca; Beerepoot, Laurens; Nieuwenhuijzen, Grard; Derks, Sarah; van Rossum, Peter S N